Categories Finance, LATEST, Markets

HSBC to cut 10,000 jobs to reduce expenses

HSBC (NYSE: HSBC) is undertaking cost-cutting initiatives that could result in the reduction of up to 10,000 jobs. According to a report by the Financial Times, this could result in a substantial reduction in the bank’s headcount of around 240,000 employees.

These efforts are part of plans being implemented by interim CEO Noel Quinn, who took over from John Flint after the latter stepped down from the role in August. The job reductions under the new plan will be in addition to the 4,700 redundancies recently announced.

HSBC to cut 10,000 jobs to reduce expenses
HSBC headquarters, London/Courtesy: HSBC Holdings plc

The report stated that the company has been facing a challenging global environment due to low interest rates, trade conflicts and uncertainties associated with Brexit. The latest cost reduction effort will be focused mostly on high-paid roles.

HSBC is attempting to find ways to reduce costs in each of its major divisions and the company is also preparing to divest its retail operation in France, which in turn is expected to reduce thousands of jobs, said the report.

Also read: Domino’s Pizza Q3 2019 Earnings Preview

Several banks have announced job reductions as the industry struggles with weak revenue and low interest rates.

In the first half of this year, HSBC reported revenues of $29.4 billion and EPS of $0.42. Adjusted revenues rose 8% while adjusted costs were up 3.5%.

The company is set to release its third quarter 2019 results at the end of October. Shares were down in premarket trading on Monday.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Also Read:  Snowflake (SNOW) creates a record as the most successful software IPO ever; stock more than doubles

Most Popular

Major earnings conferences to watch this week

After registering a slow recovery in the first half of the week, the markets pared these gains on Thursday and Friday. The weakness witnessed in the latter half of the

Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why

Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare sector through strategic partnerships and technological innovation. Its performance so

The COVID-19 pandemic gave these companies an unexpected opportunity

The COVID-19 pandemic raged through the first half of this year and continues to impact the world without signs of abating. Amid this health crisis, several companies reported strong results

Tags

Top